Molecular epidemiology of Helicobacter pylori in England: Prevalence of cag pathogenicity island markers and IS605 presence in relation to patient age and severity of gastric disease

FEMS Immunology and Medical Microbiology

Volumn 30, Issue 1, 2001, Pages 65-71

  Owen, Robert J ^a   Peters, Tansy M ^a   Varea, Ruben ^a   Teare, E Louise ^b   Saverymuttu, Seth ^c  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b Public Health Laboratory   (United Kingdom)

^c BROOMFIELD HOSPITAL   (United Kingdom)

Author keywords

Age; cag pathogenicity island; cagA; Epidemiology; Helicobacter pylori; IS605 element; Peptic ulcer disease

Indexed keywords

M PROTEIN; PROTEIN CAG A; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPEPSIA; ESOPHAGITIS; FEMALE; GENE DELETION; GENOME; GENOTYPE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENICITY; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DNA TRANSPOSABLE ELEMENTS; DYSPEPSIA; ENGLAND; EPIDEMIOLOGY, MOLECULAR; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 0035138181     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(00)00238-8     Document Type: Article

References (49)

1. The prevalence of Helicobacter pylori infection in different countries
2. Helicobacter pylori and gastric diseases
3. Is there a rationale for eradication of Helicobacter pylori? Costs benefit - The case for
4. Not all Helicobacter pylori strains are created equal: Should all be eliminated?
5. Helicobacter pylori
6. Conservation of the cytotoxin-associated (cagA) gene of Helicobacter pylori and investigation of association with vacuolating-cytotoxin activity and gastroduodenal disease
7. Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island
8. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation
9. Molecular characterisation of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer
10. Serologic detection of infection with cagA+ Helicobacter pylori strains
11. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology
12. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases
13. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls
14. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection
15. Helicobacter pylori and atrophic gastritis: Importance of the cagA status
16. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis
17. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
18. Systematic and mucosal humoral responses to in gastric cancer
19. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
20. High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients
21. Serological response to specific Helicobacter pylori antigens: Antibody against CagA antigen is not predictive of gastric cancer in a developing country
22. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: Lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis
23. Comparison of four serological tests to determine the CagA or VacA status of Helicobacter pylori strains
24. Usefulness on anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy
25. H. pylori virulence factors
26. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
27. Analysis of the cag pathogenicity island of Helicobacter pylori
28. Novel sequence organization and insertion specificity of IS605 and IS606 chimaeric transposable elements of Helicobacter pylori
29. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
30. The complete genome sequence of the gastric pathogen Helicobacter pylori
31. Preparation of genomic DNA from bacteria
32. Cloning and expression of a high molecular weight major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production
33. PCR amplification of gene sequences from Helicobacter pylori strains
34. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells
35. Did the inheritance of a pathogenicity island modify the virulence of Helicobacter pylori?
36. Conservation of the cag pathogenicity island of Helicobacter pylori: Associations with vacuolating cytotoxin allele and IS605 diversity
37. Helicobacter pylori cagA status, vacA genotypes and ulcer disease
38. cagA positive and negative Helicobacter pylori strains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: Relevance to histological damage
39. CagA and cytotoxicity of Helicobacter pylori are not markers of peptic ulcer in Japanese patients
40. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates
41. Heterogeneity in the Helicobacter pylori vacA and cagA genes: Association with gastroduodenal disease in South Africa?
42. Serologic detection of Helicobacter pylori infection with cagA-positive strains in duodenal ulcer, gastric cancer and asymptomatic gastritis
43. Clinical and pathological importance of cagA-positive Helicobacter pylori strains in children with abdominal complaints
44. Detection and characterisation of Helicobacter pylori from patients with gastroduodenal diseases
45. Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori associated diseases
46. cagA positive Helicobacter pylori populations in China and the Netherlands are distinct
47. Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes
48. Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in British dyspeptic patients
49. DNA sequence conservation and diversity in transposable element IS605 of Helicobacter pylori